Insulinomas May Hold Key to Diabetes Drug Development

Share this content:
Insulinomas May Hold Key to Diabetes Drug Development
Insulinomas May Hold Key to Diabetes Drug Development

WEDNESDAY, Oct. 4, 2017 (HealthDay News) -- An analysis of whole-exome and RNA sequencing data reveals mutations, copy number variants, and/or dysregulation of epigenetic modifying genes in insulinomas, which may be candidates for inducing beta cell regeneration, according to a study published online Oct. 3 in Nature Communications.

Huan Wang, from the Icahn Institute for Genomics and Multiscale Biology in New York City, and colleagues surveyed 38 insulinomas to explore therapeutic pathways for beta cell regeneration. The genomic and molecular landscapes of insulinomas were characterized relative to normal beta cells using an integrative analysis of whole-exome and RNA sequencing data.

The researchers found that most insulinomas exhibit mutations, copy number variants, and/or dysregulation of epigenetic modifying genes at the pathway level; these were seen most prominently in the polycomb and trithorax families. These processes were coupled with co-expression network modules that correlate with cell proliferation, indicating candidates for inducing regeneration of beta cells.

"Validation of key computational predictions supports the concept that understanding the molecular complexity of insulinoma may be a valuable approach to diabetes drug discovery," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Jury Awards 4.62B in Johnson  Johnson Talcum Powder Lawsuit

Jury Awards $4.62B in Johnson & Johnson Talcum ...

The award includes $550 million in compensatory damages and $4.14 billion in punitive damages

100 Now Sickened by Salmonella-Tainted Honey Smacks Cereal

100 Now Sickened by Salmonella-Tainted Honey Smacks Cereal

Thirty people have been hospitalized, but no deaths have been reported

Data Support FDA Restrictions on Child Cough and Cold Medicines

Data Support FDA Restrictions on Child Cough and ...

Surveillance data showed more adverse events for children exposed to hydrocodone than codeine

is free, fast, and customized just for you!




Already a member?

Sign In Now »